These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9438458)

  • 1. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.
    Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
    Cancer; 1997 Dec; 81(6):337-42. PubMed ID: 9438458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies.
    Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
    Cancer; 1997 Dec; 81(6):343-7. PubMed ID: 9438459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A feasibility study of the AutoPap system location-guided screening.
    Lee JS; Kuan L; Oh S; Patten FW; Wilbur DC
    Acta Cytol; 1998; 42(1):221-6. PubMed ID: 9479344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AutoPap system for primary screening in cervical cytology. Comparing the results of a prospective, intended-use study with routine manual practice.
    Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ
    Acta Cytol; 1998; 42(1):214-20. PubMed ID: 9479343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does use of the AutoPap assisted primary screener improve cytologic diagnosis?
    Bibbo M; Hawthorne C; Zimmerman B
    Acta Cytol; 1999; 43(1):23-6. PubMed ID: 9987445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of automated cervical cytology rescreening using the AutoPap 300 QC System.
    Stevens MW; Milne AJ; James KA; Brancheau D; Ellison D; Kuan L
    Diagn Cytopathol; 1997 Jun; 16(6):505-12. PubMed ID: 9181316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of high grade squamous intraepithelial lesions and tumors using the AutoPap System: results of a primary screening clinical trial.
    Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ; Dax Taylor D
    Cancer; 1999 Dec; 87(6):354-8. PubMed ID: 10603189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of AutoPap system-assisted and manual cytologic screening. A comparison.
    Wertlake P
    J Reprod Med; 1999 Jan; 44(1):11-7. PubMed ID: 9987733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system.
    Marshall CJ; Rowe L; Bentz JS
    Diagn Cytopathol; 1999 Mar; 20(3):170-4. PubMed ID: 10086244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AutoPap 300 QC system scoring of cervical smears without "epithelial cell abnormalities".
    Colgan TJ; Bon N; Lee JS; Patten SF
    Acta Cytol; 1997; 41(1):45-9. PubMed ID: 9022725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical trial of the AutoPap 300 QC system for quality control of cervicovaginal cytology in the clinical laboratory.
    Colgan TJ; Patten SF; Lee JS
    Acta Cytol; 1995; 39(6):1191-8. PubMed ID: 7483997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the utility and effectiveness of the NeoPath AutoPap 300 QC System used routinely.
    Fetterman B; Pawlick G; Koo H; Hartinger J; Gilbert C; Connell S
    Acta Cytol; 1999; 43(1):13-22. PubMed ID: 9987444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated cervical cytology: meta-analyses of the performance of the AutoPap 300 QC System.
    Abulafia O; Sherer DM
    Obstet Gynecol Surv; 1999 Jul; 54(7):469-76. PubMed ID: 10394585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural-network-assisted analysis and microscopic rescreening in presumed negative cervical cytologic smears. A comparison.
    Mango LJ; Valente PT
    Acta Cytol; 1998; 42(1):227-32. PubMed ID: 9479345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A feasibility study of the use of the AutoPap screening system as a primary screening and location-guided rescreening device.
    Confortini M; Bonardi L; Bulgaresi P; Cariaggi MP; Cecchini S; Ciatto S; Cipparrone I; Galanti L; Maddau C; Matucci M; Rubeca T; Troni GM; Turco P; Zappa M; Carozzi F
    Cancer; 2003 Jun; 99(3):129-34. PubMed ID: 12811852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of the AutoPap 300 QC System for cervical cytologic abnormalities. Biopsy data confirmation.
    Wilbur DC; Bonfiglio TA; Rutkowski MA; Atkison KM; Richart RM; Lee JS; Patten SF
    Acta Cytol; 1996; 40(1):127-32. PubMed ID: 8604565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity studies of AutoPap System Location-Guided Screening of cervical-vaginal cytologic smears.
    Huang TW; Lin TS; Lee JS
    Acta Cytol; 1999; 43(3):363-8. PubMed ID: 10349363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AutoPap system performance in screening for low prevalence and small cell abnormalities.
    Lee JS; Wilhelm P; Kuan L; Ellison DG; Lei X; Oh S; Patten SF
    Acta Cytol; 1997; 41(1):56-64. PubMed ID: 9022727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The primary screening clinical trials of the TriPath AutoPap System.
    Wilbur DC; Norton MK
    Epidemiology; 2002 May; 13 Suppl 3():S30-3. PubMed ID: 12071481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multi-Institutional Feasibility Study on the Use of Automated Screening Systems for Quality Control Rescreening of Cervical Cytology.
    Sugiyama Y; Sasaki H; Komatsu K; Yabushita R; Oda M; Yanoh K; Ueda M; Itamochi H; Okugawa K; Fujita H; Tase T; Nakatani E; Moriya T
    Acta Cytol; 2016; 60(5):451-457. PubMed ID: 27673689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.